英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
decisis查看　decisis　在百度字典中的解释百度英翻中〔查看〕
decisis查看　decisis　在Google字典中的解释Google英翻中〔查看〕
decisis查看　decisis　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Actithera
    At Actithera we develop innovative radiotherapeutics by linking radioactive isotopes to carefully designed molecules Our approach ensures rapid, specific, and sustained delivery of radiation to tumors, minimizing exposure to healthy tissues
  • Delivering Targeted Radioligand Cancer Therapies - actithera. com
    Actithera is dedicated to developing precisely targeted radioligand therapies to serve cancer patients with high unmet medical needs Actithera leverages proprietary chemistries to design best-in-class radioligand therapies that persist in tumors while sparing healthy tissues
  • Actithera - LinkedIn
    Actithera is a radiopharmaceutical biotech company translating medicinal chemistry insights into next-generation radioligand therapies (RLTs)
  • Actithera draws new investors to radiopharma drug pitch
    Actithera, a radiopharmaceutical drugmaker based in Oslo, Norway and Cambridge, Massachusetts, has raised just under $76 million in Series A venture financing to build out its cancer drug pipeline
  • Actithera Raises $75. 5M in Oversubscribed Series A Financing to . . .
    Actithera is a radiopharmaceutical biotech company translating medicinal chemistry insights into next-generation radioligand therapies (RLTs)
  • Actithera - Sofinnova Partners
    We are driven by a collaborative and empowering culture where talented individuals come together with a shared mission: to transform the lives of cancer patients through innovative science
  • New radiopharma Actithera emerges with $75. 5m in financing
    A new player in radioligand therapies, Actithera, has arrived on the scene with $75 5m in funding and lead FAP-targeted candidate for cancer
  • Actithera Raises $75. 5M To Play in Sizzling Radiopharma Space
    Actithera’s radiopharma assets irreversibly bind to their targets, allowing for longer retention of the drug inside tumors Massachusetts startup Actithera closed an oversubscribed series A financing Wednesday, beefing up its capital by $75 5 million to advance next-generation radiopharmaceuticals
  • Actithera Raises $75. 5M in Oversubscribed Series A Financing to . . .
    Actithera, a radiopharmaceutical biotech company translating medicinal chemistry insights into next-generation radioligand therapies (RLTs), today announced the close of an oversubscribed $75 5 million Series A financing round
  • Actithera - M Ventures
    Actithera is discovering and developing novel Radiotherapeutics for the treatment of cancer Actithera’s technology is based on unique medicinal chemistry approaches promising to deliver Radiotherapeutics with with significant differentiation and larger therapeutic windows





中文字典-英文字典  2005-2009